CCR Milestones - Highlights 2021-2022

New Faculty Andrea B. Apolo, M.D. Andrea B. Apolo, M.D., has been awarded tenure at NIH and appointed to Senior Investigator in the Genitourinary Malignancies Branch. Dr. Apolo designs and implements clinical trials to test novel agents for the treatment of urologic cancers. Her research focuses on developing targeted therapies for bladder cancer and rare genitourinary tumors. Michael B. Aregger, Ph.D. Michael B. Aregger, Ph.D., has joined the Molecular Targets Program as a Stadtman Tenure-Track Investigator. Dr. Aregger’s research focuses on metabolic plasticity in cancer cells by mapping genetic interactions and cancer dependencies using CRISPR-based genome engineering tools and functional genomics approaches. Hans Elmlund, Ph.D. Hans Elmlund, Ph.D., has joined the Center for Structural Biology as a Senior Investigator. Dr. Elmlund pioneered the use of stochastic 3D reconstruction algorithms for analyzing images obtained with cryo-electron microscopy and graphene-liquid-cell electron microscopy. His laboratory develops novel algorithmic solutions to address the most difficult problems in fields ranging from structural biology to nanoscience. Freddy E. Escorcia, M.D., Ph.D. Freddy E. Escorcia, M.D., Ph.D., has been appointed as an NIH Lasker Scholar Tenure- Track Investigator in the Molecular Imaging Branch and is a member of the NIH Distinguished Scholars Program. Dr. Escorcia aims to develop new agents to help treat and monitor cancer patients by harnessing systemic, targeted radiopharmaceuticals. Christine M. Heske, M.D. Christine M. Heske, M.D., has been appointed as a Tenure-Track Investigator in the Pediatric Oncology Branch and is a member of the NIH Distinguished Scholars Program. Dr. Heske is a physician-scientist with a research focus on novel therapeutic agents for pediatric sarcomas. Her program identifies and evaluates new therapeutic targets by understanding the mechanisms behind therapeutic resistance and developing strategies to mitigate resistance through targeting tumor metabolism and DNA damage repair. 30

RkJQdWJsaXNoZXIy Mzc5ODkz